Journal Finder

Cell Press has been chosen by The American Society of Human Genetics to publish its premier monthly journal from January 2008. The American Journal of Human Genetics (AJHG) is an exciting new venture for Cell Press as its first society-owned journal. The American Society of Human Genetics (ASHG) and Cell Press anticipate tremendous synergies between AJHG content and that of the 12 Cell Press titles, including Cell, Molecular Cell, Current Biology, and Immunity.Since its inception in 1948, The American Journal of Human Genetics has provided a record of research and review relating to heredity in humans, and to the application of genetic principles in medicine and public policy, as well as in related areas of molecular and cell biology.

Cancer Cell publishes reports of novel results in any area of cancer research, from molecular and cellular biology to clinical oncology. The work should be not only of exceptional significance within its field but also of interest to researchers outside the immediate area. In addition, Cancer Cell findings in cancer research, diagnosis and treatment. The goal ofCancer Cell is to promote the exchange of ideas and concepts across the entire cancer community, cultivating new areas of basic research and clinical investigation.Cancer Cell will consider papers for publication in any aspect of cancer biology and clinical research, including (but not limited to): Genetics, epigenetics, genomic instability • Cell signaling and communication • Cell cycle, DNA repair • Diagnostics (molecular profiling, pharmacogenomics) • Telomerase and transformation • Apoptosis • Angiogenesis, metastasis • Animal models • Cancer therapy (rational drug design, small molecule therapeutics) • Epidemiology and prevention.Visit the Cancer Cell website to find out more - http://www.cancercell.org .

For more information go to http://www.cell.com/cell-host-microbe/home

Cell Metabolism publishes reports of novel results in any area of metabolic biology, from molecular and cellular biology to translational studies. The unifying theme is homeostatic mechanisms in health and disease, from simpler model systems all the way to the clinic. Published work should not only be of exceptional significance within its field, but also of interest to researchers outside the immediate area. Cell Metabolism also provides expert analysis and commentary on key findings in the field. The journal's mission is to provide a forum for the exchange of ideas and concepts across the entire metabolic research community, cultivating new areas and fostering cross-disciplinary collaborations in basic research and clinical investigation. Cell Metabolism publishes papers in any aspect of basic and translational metabolic research, including (but not limited to):Adipogenesis/lipidsObesityDiabetesCardiovascular diseaseHypertensionBone homeostasisAging and stress responseEnergy balanceMitochondriaHormone receptorsFor more information please visit www.cellmetabolism.org

The journal publishes theoretical and research papers on cognitive brain development, from infancy through childhood and adolescence and into adulthood. It covers neurocognitive development and neurocognitive processing in both typical and atypical development, including social and affective aspects. Appropriate methodologies for the journal include, but are not limited to, functional neuroimaging (fMRI and MEG), electrophysiology (EEG and ERP), NIRS and transcranial magnetic stimulation, as well as other basic neuroscience approaches using cellular models that directly address cognitive brain development, patient studies, case studies, post-mortem studies and pharmacological studies. Note that we are no longer considering animal models.

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Cell Reports Methods is an open access, multidisciplinary journal from Cell Press publishing significant methodological advances of broad interest. The primary criterion for publication in Cell Reports Methods is a robust, reproducible method that will spur scientific progress. We will also consider papers presenting a new tool or set of reagents that will be of significant utility and interest to the community. Cell Reports Methods publishes shorter, single-point stories, called Reports, in addition to a longer Article format. Areas of interest include innovations in sequencing and imaging technologies, genome editing, single-molecule approaches, computational methods, biotechnology, and synthetic biology.

Chem provides a home for seminal and insightful research and showcases how exceptional fundamental studies in chemistry and its sub-disciplines may help to find potential solutions to the global challenges of tomorrow. Chem is committed to providing authors with a fast, fair, informed, and responsive review process. Our PhD-trained scientific editors work with authors, reviewers, and editorial board members with the goal of publishing the most interesting discoveries in chemistry each year. 

Current Biology is widely valued among life scientists for its unique blend of important research papers and informed, lively commentary. Published every 2 weeks, the journal delivers exciting primary research from all areas of biology, from molecular biology to evolution. Current Biology also features timely Dispatches - commentary by leading experts on the latest advances - as well as valuable full-length reviews and a vibrant magazine section that includes news, analysis and opinion, profiles of leading scientists and institutions, and informative, accessible guides to notable topics in biology.Current Biology features research and commentary in all areas of biology, including:Cell Biology, Cell Signaling, Cell Cycle Regulation, and ApoptosisDevelopmental BiologyCellular and Systems NeuroscienceCancer BiologyGene Expression, including Genomics & ProteomicsDNA and RNA Metabolism, including Transcription and TranslationPlant BiologyImmunologyEcology and EvolutionCurrent Biology has earnerd a leading Impact Factor among biology journals of its scope. Visit the Current Biology website to learn more.

Molecular Cell is a companion to Cell, the leading journal of biology and the highest-impact journal in the world.Launched in December 1997 and published monthly, Molecular Cell defines the field of molecular biology with a relatively small number of significant papers, up to 15 articles per issue. Coverage will extend from structure to human diseases, concentrating on molecular analyses. Topics that will be represented in the first issues include gene expression, RNA processing, replication, recombination and repair, structure, chaperones, receptors, signal transduction, cell cycle, and tumorigenesis.The majority of papers published in Molecular Cell are articles in the format familiar from Cell. However, we will also publish short papers (up to 6 published pages) that make focused contributions on points of general interest. The publication schedule will be rapid: on our regular monthly schedule, publication time should average 6 weeks from acceptance.Visit the Molecular Cell website to find out more - http://www.molecule.org/

Molecular Plant is a recently founded international journal that publishes significant findings in plant biology, focusing broadly on cellular biology, physiology, molecular biology, genetics, development, and evolution.The journal features a strong international editorial board and is set to become a top-tier journal in the field, using rigorous review to limit the journal to papers that provide novel insights of high impact. The editors particularly encourage submissions of original research that is highly novel but not necessarily fully-developed. Contributions may comprise Research Articles, Review Articles, Methods, Editorials, and Commentaries.To set the standard for its future, most of the papers published in Molecular Plant's first two years were commissioned by editorial members and published in Special Issues on particularly exciting and important topics in current plant biology. Now that the journal's standard has been established, Molecular Plant now receives large numbers of high-quality unsolicited submissions, which have been published under the heading 'Topics of General Interest' since May 2009.The journal is steadily increasing the proportion of regular submissions published. Plant biology authors are strongly encouraged to submit their best work to the journal. Every effort is made to ensure papers are fully reviewed within four weeks and that all accepted papers are published online in their final format within four weeks of arrival of the finished manuscript at the publisher.Assessment by the China Association for Science and Technology of ‘top journals in China’ (in 2010) rated Molecular Plant one of seven A-class journals. .

Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide- and protein-, oligonucleotide- and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Available in print and online, Molecular Therapy is dedicated to promoting the sciences in genetics, medicine and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2009 impact factor is 6.239*.

methods, technology development, molecular therapy, gene therapy